Autolus Therapeutics (AUTL) Earnings Analysis
Autolus Therapeutics (AUTL) next reports earnings on 2026-08-11, consensus EPS -0.22 USD. Last quarter (2026-05-14) it beat with EPS -0.27 USD vs -0.29 USD est (+6.9%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -1.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AUTL next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.22 USD |
| Revenue estimate | 0.03B |
AUTL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.27 USD | -0.29 USD | +6.9% | Beat |
| 2026-03-27 | -0.34 USD | -0.25993 USD | -30.8% | Miss |
| 2025-05-08 | -0.26 USD | -0.24 USD | -8.3% | Miss |
| 2025-03-20 | -0.09 USD | -0.21 USD | +57.1% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
AUTL valuation and analyst view
| Trailing P/E | -1.32 |
|---|---|
| Trailing EPS | -1.08526 USD |
| Price / book | 3.52 |
| Dividend yield | 0.00% |
| Market cap | 0.38B |
| Analyst consensus | Buy (11 buy / 3 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Autolus Therapeutics (AUTL)'s next earnings date?
Autolus Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.22 USD and revenue estimate of 0.03B.
Did AUTL beat earnings last quarter?
In its 2026-05-14 report, AUTL posted EPS of -0.27 USD versus a -0.29 USD estimate — a beat of 6.9%.
What is AUTL's earnings track record?
Over the last 4 reported quarters with consensus data, AUTL beat estimates 2 times (50%).
What is AUTL's current P/E ratio and EPS?
AUTL trades at a trailing P/E of -1.32 on trailing EPS of -1.08525878856485 USD.
What do analysts rate AUTL?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 11 buy, 3 hold, 0 sell, 0 strong sell).